Brachytherapy Seed with Fast Dissolving Matrix for Optimal Delivery of Radionuclides to Cancer Tissue
Abstract
A system, method and device for treating tumor cells utilizing a resorbable therapy seed made up of microspheres containing a beta- or alpha-particle-emitting radiation source and a resorbable polymer matrix. These seeds are implanted within the tumor and then rapidly dissolved so as to release the microspheres from the polymer matrix. These microspheres then spread within a preselected target area and provide radiation therapy in a predetermined amount and at a preselected rate according the specific needs and necessities of the users. The configuration of the microspheres, the types of radiation provided and the location and use of these microspheres provides desired localized treatment to target cells while preferentially avoiding or minimizing undesired damage to surrounding tissue. The present invention provides a method for making the seeds, as well as a method for utilizing the seeds as a part of the treatment method.
Claims
exact text as granted — not AI-modified1 - 21 . (canceled)
22 . A brachytherapy seed comprising individual particles of sorbitol coated, each individual particle being coated with a biodegradable polymer.
23 . The brachytherapy seed of claim 22 further comprising a radioisotope.
24 . The brachytherapy seed of claim 23 wherein the radioisotope is a beta-particle-emitting radionuclide.
25 . The brachytherapy seed of claim 23 wherein the radioisotope is one of yttrium-90, rhenium-186, rhenium-188, or lutetium-177.
26 . The brachytherapy seed of claim 23 wherein the radioisotope is an alpha-particle-emitting radionuclide.
27 . The brachytherapy seed of claim 23 wherein the radioisotope is one of actinium-225, bismuth-213, bismuth-212, thorium-227, radium-223, astatine-211, or terbium-149.
28 . The brachytherapy seed of claim 22 further comprising at least one marker.
29 . The brachytherapy seed of claim 28 wherein the marker comprises radio opaque material.
30 . The brachytherapy seed of claim 22 further comprising an anti-inflammatory agent.
31 . The brachytherapy seed of claim 22 wherein the polymer comprises one or both of PLA and PLGA.
32 . The brachytherapy seed of claim 22 wherein the polymer has a molecular weight ranging from 5,000 to 100,000.
33 . The brachytherapy seed of claim 22 wherein the polymer comprises both PLA and PLGA, the ratio of PLA to PLGA being from about 3:1 to about 1:1.
34 . The brachytherapy seed of claim 22 wherein the polymer is provided to constitute from 0.5 to 5 percent of the seed.
35 . A method for preparing a brachytherapy seed, the method comprising:
providing a structure comprising a radioisotope; providing a mixture of particles, individual ones of the particles comprising sorbitol, each individual particle being coated with a biodegradable polymer; and pressing the mixture of particles about the structure to form a brachytherapy seed comprising the particles.
36 . The method of claim 35 wherein the providing the mixture of particles comprises binding the sorbitol with the polymer to form the particles.
37 . The method of claim 35 wherein the polymer comprises one or both of PLA and PLGA.
38 . The method of claim 35 wherein the polymer has a molecular weight ranging from 5,000 to 100,000.
39 . The method of claim 35 wherein the polymer comprises both PLA and PLGA, the ratio of PLA to PLGA being from about 3:1 to about 1:1.
40 . The method of claim 35 wherein the polymer is provided to constitute from 0.5 to 5 percent of the seed.
41 . The method of claim 35 wherein the providing the mixture of particles comprises binding the sorbitol with the polymer to form the particles.
42 . The method of claim 41 wherein the polymer is natural.Join the waitlist — get patent alerts
Track US2016193479A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.